These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31673530)

  • 21. Treatment outcomes of gonadotropin-releasing hormone agonist in obese girls with central precocious puberty.
    Kim HR; Nam HK; Rhie YJ; Lee KH
    Ann Pediatr Endocrinol Metab; 2017 Dec; 22(4):259-265. PubMed ID: 29301187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adult height after spontaneous pubertal growth or GnRH analog treatment in girls with early puberty: a meta-analysis.
    Bertelloni S; Massart F; Miccoli M; Baroncelli GI
    Eur J Pediatr; 2017 Jun; 176(6):697-704. PubMed ID: 28364286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of a 4-year combination therapy of growth hormone and gonadotropin-releasing hormone analogue in pubertal girls with short predicted adult height.
    Dotremont H; France A; Heinrichs C; Tenoutasse S; Brachet C; Cools M; De Waele K; Massa G; Lebrethon MC; Gies I; Van Besien J; Derycke C; Ziraldo M; De Schepper J; Beauloye V; Verhulst S; Rooman R; den Brinker M
    Front Endocrinol (Lausanne); 2023; 14():1113750. PubMed ID: 37008942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should Skeletal Maturation Be Manipulated for Extra Height Gain?
    Wit JM
    Front Endocrinol (Lausanne); 2021; 12():812196. PubMed ID: 34975773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal follow-up to near final height of auxological changes in girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analog and grouped by pretreatment body mass index level.
    Park J; Hwang TH; Kim YD; Han HS
    Ann Pediatr Endocrinol Metab; 2018 Mar; 23(1):14-20. PubMed ID: 29609441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gonadotropin releasing hormone agonist treatment to increase final stature in children with precocious puberty: a meta-analysis.
    Li P; Li Y; Yang CL
    Medicine (Baltimore); 2014 Dec; 93(27):e260. PubMed ID: 25501098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adult Height of Patients with SHOX Haploinsufficiency with or without GH Therapy: A Real-World Single-Center Study.
    Dantas NCB; Funari MFA; Vasques GA; Andrade NLM; Rezende RC; Brito V; Scalco RC; Arnhold IJP; Mendonca BB; Jorge AAL
    Horm Res Paediatr; 2022; 95(3):264-274. PubMed ID: 35390795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of the combined recombinant human growth hormone and gonadotropin-releasing hormone analog therapy in pubertal patients with short stature due to SHOX deficiency.
    Scalco RC; Melo SS; Pugliese-Pires PN; Funari MF; Nishi MY; Arnhold IJ; Mendonca BB; Jorge AA
    J Clin Endocrinol Metab; 2010 Jan; 95(1):328-32. PubMed ID: 19926713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on the final height of girls with isolated GH deficiency: results from a controlled study.
    Saggese G; Federico G; Barsanti S; Fiore L
    J Clin Endocrinol Metab; 2001 May; 86(5):1900-4. PubMed ID: 11344181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aromatase Inhibitor Increases the Height of Patients with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.
    Xi W; Mao J; Li S; Zhao Y; Nie M; Yu B; Gao Y; Lu L; Wu X
    Endocr Pract; 2020 Sep; 26(9):997-1002. PubMed ID: 33471705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of gonadotropin releasing hormone analogue therapy on girls with gonadotropin-dependent precocious puberty.
    Tung YC; Lee JS; Tsai WY; Hsiao PH
    J Formos Med Assoc; 2007 Oct; 106(10):826-31. PubMed ID: 17964961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.
    Poomthavorn P; Suphasit R; Mahachoklertwattana P
    Gynecol Endocrinol; 2011 Aug; 27(8):524-8. PubMed ID: 21501002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Impact of gonadotropin-releasing hormone analogs on body mass index in girls with idiopathic central precocious puberty: a long-term follow-up study].
    Yuan JN; Liang L; Cai XD; Li Z; Bai M; Gu CP
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov; 13(11):896-9. PubMed ID: 22099200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes after gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty.
    Shim YS; Lim KI; Lee HS; Hwang JS
    PLoS One; 2020; 15(12):e0243212. PubMed ID: 33301485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Impact of gonadotropin-releasing hormone analogs treatment on final height in girls with central precocious puberty].
    Chen SK; Fan X; Tang Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):374-6. PubMed ID: 19470261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of gonadotropin-releasing hormone agonist treatment on near final height in girls with central precocious puberty and early puberty.
    Yang EH; Jo HY; Park SJ; Yoo HW; Choi SH; Kim HY; Park KH; Kim YM; Kwak MJ
    Ann Pediatr Endocrinol Metab; 2023 Mar; 28(1):49-53. PubMed ID: 37015776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A meta-analysis of combination therapy with gonadotrophin-releasing hormone agonist and growth hormone for children with idiopathic short stature and normal timed puberty.
    Zhou B; Liu S; Wang J; Zhang T; Yuan Y; Niu W; Zhang Z; Wang L
    Endocrine; 2022 Mar; 75(3):698-708. PubMed ID: 35083638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased final adult height by gonadotropin-releasing hormone agonist in girls with idiopathic central precocious puberty.
    Lee HS; Yoon JS; Park KJ; Hwang JS
    PLoS One; 2018; 13(8):e0201906. PubMed ID: 30133462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.